Home > PE Ratio > CONCORD BIOTECH

CONCORD BIOTECH
PE (Price/Earnings) Ratio

The Current P/E Ratio of CONCORD BIOTECH is 44.72.

Share Price ₹1,527.5Oct 16,2025
Market Cap ₹15,977.7 Cr
Earnings-TTM₹357.3 CrTTM-Consolidated Results
Price/Earnings44.72xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of CONCORD BIOTECH

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of CONCORD BIOTECH is calculated as :

Current Market Cap [ ₹15,977.7 Cr] as on Oct 16,2025

(/) Earnings [ ₹357.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.72x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for CONCORD BIOTECH , the investors are currently willing to pay 44.72 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CONCORD BIOTECH !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of CONCORD BIOTECH over the last five years.

Historical PE (Price/Earnings) ratio chart of CONCORD BIOTECH


PE Ratio Performance Analysis for CONCORD BIOTECH

- CONCORD BIOTECH 's latest p/e ratio is 44.72x.

- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.77x.

- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 51.68x.

- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does CONCORD BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
CONCORD BIOTECH 357.2944.7215,977.7
SUN PHARMACEUTICAL INDUSTRIES LTD10,411.5038.25398,218.0
DIVIS LABORATORIES LTD2,306.0075.96175,158.0
CIPLA LTD5,406.8123.44126,710.0
TORRENT PHARMACEUTICALS LTD2,002.0059.73119,586.0
DR REDDYS LABORATORIES LTD5,726.7018.07103,496.0
MANKIND PHARMA LTD1,905.5153.17101,320.0
ZYDUS LIFESCIENCES LTD4,637.8021.3599,013.4
LUPIN LTD3,722.1823.9489,093.5
AUROBINDO PHARMA LTD3,417.9318.7964,222.1
ABBOTT INDIA LTD1,452.2943.6563,398.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CONCORD BIOTECH 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.07x
Max industry PE 75.96x
Median industry PE 38.25x
Average industry PE 38.28x



You may also like the below Video Courses